ZTS Covered Call Strategy
ZTS (Zoetis Inc.), in the Healthcare sector, (Drug Manufacturers - Specialty & Generic industry), listed on NYSE.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists.
ZTS (Zoetis Inc.) trades in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a market capitalization of approximately $31.17B, a trailing P/E of 11.87, a beta of 0.86 versus the broader market, a 52-week range of 74.29-172.23, average daily share volume of 4.7M, a public-listing history dating back to 2013, approximately 14K full-time employees. These structural characteristics shape how ZTS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.86 places ZTS roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 11.87 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price. ZTS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a covered call on ZTS?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current ZTS snapshot
As of May 15, 2026, spot at $74.01, ATM IV 39.70%, IV rank 33.63%, expected move 11.38%. The covered call on ZTS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this covered call structure on ZTS specifically: ZTS IV at 39.70% is mid-range versus its 1-year history, so the credit collected on a ZTS covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 11.38% (roughly $8.42 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated ZTS expiries trade a higher absolute premium for lower per-day decay. Position sizing on ZTS should anchor to the underlying notional of $74.01 per share and to the trader's directional view on ZTS stock.
ZTS covered call setup
The ZTS covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With ZTS near $74.01, the first option leg uses a $80.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed ZTS chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 ZTS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $74.01 | long |
| Sell 1 | Call | $80.00 | $1.58 |
ZTS covered call risk and reward
- Net Premium / Debit
- -$7,243.50
- Max Profit (per contract)
- $756.50
- Max Loss (per contract)
- -$7,242.50
- Breakeven(s)
- $72.44
- Risk / Reward Ratio
- 0.104
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
ZTS covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on ZTS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$7,242.50 |
| $16.37 | -77.9% | -$5,606.21 |
| $32.74 | -55.8% | -$3,969.92 |
| $49.10 | -33.7% | -$2,333.63 |
| $65.46 | -11.6% | -$697.33 |
| $81.82 | +10.6% | +$756.50 |
| $98.19 | +32.7% | +$756.50 |
| $114.55 | +54.8% | +$756.50 |
| $130.91 | +76.9% | +$756.50 |
| $147.28 | +99.0% | +$756.50 |
When traders use covered call on ZTS
Covered calls on ZTS are an income strategy run on existing ZTS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
ZTS thesis for this covered call
The market-implied 1-standard-deviation range for ZTS extends from approximately $65.59 on the downside to $82.43 on the upside. A ZTS covered call collects premium on an existing long ZTS position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether ZTS will breach that level within the expiration window. Current ZTS IV rank near 33.63% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on ZTS should anchor more to the directional view and the expected-move geometry. As a Healthcare name, ZTS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to ZTS-specific events.
ZTS covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. ZTS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move ZTS alongside the broader basket even when ZTS-specific fundamentals are unchanged. Short-premium structures like a covered call on ZTS carry tail risk when realized volatility exceeds the implied move; review historical ZTS earnings reactions and macro stress periods before sizing. Always rebuild the position from current ZTS chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on ZTS?
- A covered call on ZTS is the covered call strategy applied to ZTS (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With ZTS stock trading near $74.01, the strikes shown on this page are snapped to the nearest listed ZTS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are ZTS covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the ZTS covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 39.70%), the computed maximum profit is $756.50 per contract and the computed maximum loss is -$7,242.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a ZTS covered call?
- The breakeven for the ZTS covered call priced on this page is roughly $72.44 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current ZTS market-implied 1-standard-deviation expected move is approximately 11.38%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on ZTS?
- Covered calls on ZTS are an income strategy run on existing ZTS stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current ZTS implied volatility affect this covered call?
- ZTS ATM IV is at 39.70% with IV rank near 33.63%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.